Gene Solutions participated in ASCO Breakthrough 2026 by inviting Dr. Tom Wei-Wu Chen from National Taiwan University Hospital to share insights on the ongoing MELODY study exploring treatment strategies in soft tissue sarcoma and MRD testing.
Published
Signal category
Research & Knowledge
Quote
“At ASCO Breakthrough 2026, we invited Dr. Tom Wei-Wu Chen, National Taiwan University Hospital (NTUH), whose expertise spans breast cancer and sarcoma, to share insights on the ongoing MELODY study.”
— Gene Solutions team
Company
Gene Solutions
We believe everyone deserves better healthcare via genetic testing.
- Industry
- Biotechnology Research
- Location
- Singapore, SG
- Company size
- 361 employees
Gene Solutions is an international biotechnology company headquartered in Singapore. We provide a comprehensive genetic testing portfolio powered by Next-Generation Sequencing and proprietary Artificial Intelligence algorithms. Our specialized services include cell-free DNA non-invasive prenatal testing, circulating tumor DNA cancer screening, genomic profiling, and treatment monitoring. Since our founding in 2017, Gene Solutions has built a global network of 14 NGS laboratories, featuring three central CAP-accredited facilities in Singapore, Vietnam, and the USA. Having delivered over three million tests to date, we are dedicated to providing accessible genetic insights to more than 5,000 hospitals and clinics across Southeast Asia, Greater China, India, Turkey, Brazil, and the USA.
Founded 2017